KALA - Kala Pharmaceuticals EPS misses by $0.01 misses on revenue May, 05 2021 07:03 AM Kala Pharmaceuticals Inc. Kala Pharmaceuticals (KALA): Q1 GAAP EPS of -$0.49 misses by $0.01.Revenue of $3.27M (+205.6% Y/Y) misses by $0.23M.Press Release For further details see: Kala Pharmaceuticals EPS misses by $0.01, misses on revenue